MedPath

ATROPINE SULFATE INJECTION USP

ATROPINE SULFATE INJECTION USP

Discontinued
DIN Number

02472171

Drug Class

Human

Market Date

Mar 25, 2020

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02472171
AIG Number0104748003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A03BA01 ATROPINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Intramuscular ,  Subcutaneous
AHFS Classification12:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

ATROPINE SULFATEActive
Strength: 0.5 MG / 5 ML
Monograph: ATROPINE SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.